Finance

Beta
Lists
330350:KOSDAQ
Withus Pharmaceutical Co Ltd
â‚©6,760.00
-2.73%
(-190.00) 1D
Jun 1, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 330350...
Open
â‚©6,950
High
â‚©6,950
Low
â‚©6,670
Mkt. cap
89.25B
Avg. vol.
95.96K
Volume
66.92K
P/E ratio
12.24
52-wk high
â‚©11,950
52-wk low
â‚©6,200
EPS
â‚©552
Shares outstanding
13.20M
No. of employees
223
Open
â‚©6,950
High
â‚©6,950
Low
â‚©6,670
Mkt. cap
89.25B
Avg. vol.
95.96K
Volume
66.92K
P/E ratio
12.24
52-wk high
â‚©11,950
52-wk low
â‚©6,200
EPS
â‚©552
Shares outstanding
13.20M
No. of employees
223
News stories
From sources across the web
About Withus Pharmaceutical Co Ltd
CEO-
Employees223
Founded2004
Headquarters-
SectorPharmaceutical industry
Websitewithuspharm.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
26.25B
27.25B
27.18B
28.22B
Cost of goods sold
9.88B
9.53B
9.88B
10.00B
Cost of revenue
9.88B
9.53B
9.88B
10.00B
Research and development expenses
-
-
452.18M
565.05M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.54B
16.35B
15.00B
16.79B
Operating expense
15.54B
16.35B
15.92B
17.98B
Total operating expenses
25.41B
25.88B
25.80B
27.97B
Operating income
830.51M
1.37B
1.38B
244.17M
Other non operating income
662.41M
1.26B
-108.94M
113.80M
EBT including unusual items
1.49B
2.63B
-1.57B
711.51M
EBT excluding unusual items
1.49B
2.63B
1.26B
370.21M
Income tax expense
197.07M
483.36M
-1.45B
-3.26B
Effective tax rate
13.20%
18.39%
92.33%
-458.19%
Other operating expenses
-
-
40.81M
53.43M
Net income
1.30B
2.14B
-120.28M
3.97B
Net profit margin
4.94%
7.87%
-0.44%
14.08%
Earnings per share
-
-
-
-
Interest and investment income
-
-
151.87M
155.00M
Interest expense
-
-
-165.04M
-138.27M
Net interest expenses
-
-
-13.17M
16.73M
Depreciation and amortization charges
-
-
92.72M
149.77M
EBITDA
1.84B
2.41B
2.43B
1.32B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer